14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Thu, 25 Apr 2024

ARNA Predictions History

4 years ago
NameNotImportant predicted that ARNA for 2019-04-29 is going $46.62 (-0.55%)

5 years ago
Bernard.Kalish.100493 predicted that ARNA for 2019-02-19 is going $56.00 (12.90%)

Rank:

5 years ago
Gp predicted that ARNA for 2019-02-19 is going $49.30 (-1.24%)

5 years ago
JS predicted that ARNA for 2019-02-19 is going $49.64 (-0.56%)

5 years ago
PumpTheseNumbers predicted that ARNA for 2019-02-19 is going $49.48 (-0.88%)

5 years ago
Ahmed.Al.Wogayan.101412 predicted that ARNA for 2019-02-19 is going $53.00 (6.17%)

Rank:

5 years ago
JS predicted that ARNA for 2018-10-09 is going $40.50 (2.04%)

6 years ago
JS predicted that ARNA for 2018-04-05 is going $37.45 (4.84%)

6 years ago
Jorge.Burke.Jr..23383 predicted that ARNA for 2018-04-05 is going $42.00 (12.72%)

Rank:

6 years ago
Andrew.Healy.12215 predicted that ARNA for 2017-11-01 is going $28.21 (0.64%)

Rank:
Click to get the best stock tips daily for free!

About Arena Pharmaceuticals

Arena Pharmaceuticals Arena Pharmaceuticals, Inc., a biopharmaceutical company, focuses on providing novel medicines with pharmacology and pharmacokinetics to patients worldwide. The company's investigational clinical programs include Etrasimod (APD334) that is in Phase III clinical trial for ulcerative colitis, Phase IIb/III clinical trial for Crohn's disease, Phase II clinical trial for alopecia areata, Phase III clinical trial for atopic dermatitis, and Phase IIb c... ARNA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT